Woman with open arms, seen from the back, looking at the sea

Media & Investors

Millions of Americans Suffer from Pain and are in Urgent Need for a Safe, Non-Addictive and Effective Treatment for Pain

Approximately 100 million Americans suffer from chronic pain. According to the CDC, chronic pain contributes to an estimated $560 billion each year in direct and indirect costs. Several U.S. government agencies, including the National Institutes of Health (NIH) and Food and Drug Administration (FDA), have identified the development of safe and effective treatments for pain as a pressing unmet medical need, especially in the wake of the U.S. Opioid Crisis.

EicOsis is Developing a Better Option for Pain and Inflammation

At EicOsis, we recognize the needs of those living with pain and inflammatory conditions. We are developing a completely new class of safe and effective oral drugs. Our pain drugs have a high potential to provide the benefits of a safe and effective pain therapy without the risks of current options for pain relief.

We have completed a Phase 1a clinical trial showing safety, tolerance and an ideal pharmacokinetic profile of the potent sEH inhibitor EC5026. We are positioned to reach efficacy trials in the next year and we are developing partnering strategies  to continue development. Learn how we are redefining pain management and making progresses to deliver better drugs to treat pain and inflammation.

Additional Resources

Pain management has been identified as a priority health issue by several international and national organizations and the challenges of its pharmacologic treatment have been emphasized by international clinical societies and acknowledged by the FDA as part of their series of Patient-Focused Drug Development Initiatives. Learn more about the unmet needs of pain management: